Variant NM_000492.4:c.2991G>C


Variant details:
Name NM_000492.4:c.2991G>C
Protein name NP_000483.3:p.(Leu997Phe)
Genomic name (hg19) chr7:g.117250575G>C    UCSC    gnomAD
#Exon/intron exon 19
Legacy Name L997F
Class disease-causing
Subclass CFTR-RD-causing
WT sequence ACATGTTTTCTTTGATCTTACAGTT G TTATTAATTGTGATTGGAGCTATAG
Mutant sequence ACATGTTTTCTTTGATCTTACAGTT C TTATTAATTGTGATTGGAGCTATAG


External sources:
dbSNP
rs1800111



Reference PMID Splicing mRNA level Maturation Localization Channel fonction (Cl-) Bicarbonate
Van Goor et al, 2014 23891399
Sosnay et al, 2013 23974870
LaRusch et al, 2014 25033378
Bergougnoux et al, 2015 25797027


« ✓ » indicates the type of analysis performed and not the results



Modulator FDA approval EMA approval in vitro / ex vivo data clinical data
IVA yesnoyesno
TEZ-IVA yesnoyesno
ELX-TEZ-IVA yesnoyesno


clinical and functional data are provided by Vertex


Pathogenicity predictions:
AGVGD MAPP SIFT PPH2
C0 0.06646 0.06 0.999
VUS1 VUS2 VUS4 VUS5

Color code:   non disease-causing <   VUS1 <   VUS2 <   VUS3 <   VUS4 <   VUS5 <   disease-causing




4 individuals carrying this variant are reported in CFTR-NGS catalogue


110 patients carrying this variant are reported in CFTR-France:

TOTAL NUMBER OF PATIENTS 110
Asymptomatic compound heterozygote 10
CF 3
CFTR-RD88
  • Aquagenic palmoplantar keratoderma  2
  • Bronchiectasis  9
  • CBAVD  34
  • CRS-NP  2
  • Other  6
  • Pancreatitis  35
Fetal bowel anomalies 1
Pending 2
Pending (NBS) 6



Detailed genotypes:
Phenotype Patient ID Variant status Additional variants
Pancreatitis 5894heterozygoteVUS4- Undef
Pancreatitis 2198heterozygoteCFTR-RD-causing- Undef
Pancreatitis 2242heterozygoteCFTR-RD-causing- Undef
CFTR-RD-causing- Undef
CFTR-RD-causing- Undef
Pancreatitis 2285heterozygote
Pancreatitis 2346heterozygoteCF-causing- Undef
Pancreatitis 2483heterozygote
Pancreatitis 2486heterozygoteVUS3- Undef
VUS1- Undef
Pancreatitis 5879heterozygoteCFTR-RD-causing- Undef
Pancreatitis 1836heterozygoteCF-causing- Undef
Pancreatitis 5102heterozygoteVUS2- Undef
Pancreatitis 5368heterozygotevarying clinical consequence- Undef
Pancreatitis 5388heterozygoteVUS2- Undef
Pancreatitis 5453heterozygoteCF-causing- Undef
Pancreatitis 5454heterozygoteCF-causing- Undef
Pancreatitis 5455heterozygoteCF-causing- Undef
Pancreatitis 5668heterozygoteCF-causing- Undef
Pancreatitis 5700heterozygoteCFTR-RD-causing- Undef
Pancreatitis 5870heterozygoteVUS3- Undef
VUS1- Undef
Pancreatitis 4918heterozygoteVUS3- Undef
Pancreatitis 5010heterozygoteCFTR-RD-causing- Undef
Pancreatitis 5623heterozygoteCFTR-RD-causing - Trans
CFTR-RD-causing - Trans
CFTR-RD-causing - Trans
Pancreatitis 4318heterozygoteCFTR-RD-causing- Undef
Pancreatitis 3312heterozygote
Pancreatitis 2748heterozygoteCFTR-RD-causing- Undef
CFTR-RD-causing- Undef
Pancreatitis 2785heterozygote
Pancreatitis 2786heterozygoteCF-causing - Trans
Pancreatitis 3182heterozygoteCF-causing- Undef
Pancreatitis 76heterozygoteCF-causing - Trans
Pancreatitis 964heterozygoteVUS4 - Trans
Pancreatitis 1650heterozygoteCFTR-RD-causing- Undef
Pancreatitis 4977heterozygoteCF-causing- Undef
Pancreatitis 5145heterozygoteCF-causing- Undef
Pancreatitis 5125homozygotec.2991G>C - p.(Leu997Phe) - Trans
Pancreatitis 5862homozygotec.2991G>C - p.(Leu997Phe) - Trans
Pancreatitis 4926homozygotec.2991G>C - p.(Leu997Phe) - Trans
Pending (NBS) 2038heterozygoteCF-causing- Undef
Pending (NBS) 4666heterozygoteCF-causing - Trans
Pending (NBS) 4693heterozygoteCF-causing - Trans
Pending (NBS) 4667heterozygoteCF-causing - Trans
Pending (NBS) 352heterozygoteCF-causing - Trans
Pending (NBS) 5183heterozygoteCF-causing - Trans
VUS3- Undef
Bronchiectasis 1985heterozygoteCF-causing- Undef
Bronchiectasis 2367heterozygote
Bronchiectasis 4906heterozygoteCFTR-RD-causing - Trans
Bronchiectasis 4613heterozygote
Bronchiectasis 3213heterozygoteCF-causing - Cis
varying clinical consequence - Trans
Bronchiectasis 560heterozygoteCF-causing- Undef
Bronchiectasis 4726heterozygotevarying clinical consequence- Undef
Bronchiectasis 4866heterozygoteCF-causing- Undef
Bronchiectasis 5153homozygotec.2991G>C - p.(Leu997Phe) - Trans
Other 4582heterozygoteCF-causing- Undef
Other 2696heterozygotevarying clinical consequence- Undef
Other 4664heterozygoteCF-causing- Undef
Other 645heterozygoteCF-causing- Undef
Other 4842heterozygoteVUS3 - Trans
Other 5201heterozygoteCF-causing- Undef
CBAVD 4905heterozygoteCF-causing- Undef
CBAVD 5871heterozygoteCF-causing- Undef
CBAVD 5444heterozygoteCF-causing- Undef
CBAVD 4919heterozygoteCF-causing- Undef
CBAVD 3361heterozygoteCF-causing- Undef
CBAVD 3366heterozygoteCF-causing- Undef
CBAVD 3377heterozygoteCF-causing - Trans
CBAVD 4586heterozygote
CBAVD 3318heterozygoteVUS3 - Trans
VUS1 - Trans
CBAVD 2689heterozygoteCF-causing- Undef
CBAVD 4589heterozygote
CBAVD 510heterozygote
CBAVD 513heterozygoteCF-causing - Trans
CBAVD 525heterozygoteCF-causing - Trans
CBAVD 538heterozygoteCFTR-RD-causing - Trans
CFTR-RD-causing - Trans
CBAVD 707heterozygote
CBAVD 736heterozygoteCF-causing- Undef
CBAVD 489heterozygoteCFTR-RD-causing - Trans
CBAVD 483heterozygoteCF-causing- Undef
CBAVD 428heterozygoteCF-causing - Trans
CBAVD 447heterozygoteCF-causing- Undef
CBAVD 461heterozygoteCF-causing- Undef
CBAVD 462heterozygoteCF-causing- Undef
CFTR-RD-causing- Undef
CBAVD 469heterozygoteCF-causing- Undef
CBAVD 482heterozygote
CBAVD 849heterozygoteCF-causing- Undef
CBAVD 1294heterozygoteCFTR-RD-causing- Undef
CFTR-RD-causing- Undef
CFTR-RD-causing- Undef
CBAVD 1464heterozygoteVUS3 - Trans
VUS1 - Trans
CBAVD 1487heterozygoteCF-causing- Undef
CBAVD 1634heterozygoteCF-causing- Undef
CBAVD 1655heterozygoteCF-causing- Undef
CBAVD 1759heterozygoteCF-causing- Undef
CBAVD 5819heterozygoteCF-causing- Undef
CBAVD 981heterozygoteCFTR-RD-causing- Undef
Asymptomatic compound heterozygote 4749heterozygoteCF-causing - Trans
Asymptomatic compound heterozygote 3235heterozygoteVUS3 - Trans
Asymptomatic compound heterozygote 558heterozygoteCF-causing - Trans
Asymptomatic compound heterozygote 575heterozygoteCFTR-RD-causing - Trans
Asymptomatic compound heterozygote 740heterozygoteCFTR-RD-causing - Trans
CFTR-RD-causing - Trans
Asymptomatic compound heterozygote 4960heterozygoteVUS1- Undef
Asymptomatic compound heterozygote 5222heterozygoteVUS3- Undef
Asymptomatic compound heterozygote 5815heterozygote
Asymptomatic compound heterozygote 965heterozygoteVUS4 - Trans
Asymptomatic compound heterozygote 739homozygotec.2991G>C - p.(Leu997Phe) - Trans
Fetal bowel anomalies 828heterozygoteCF-causing - Trans
Aquagenic palmoplantar keratoderma 4827heterozygoteCF-causing- Undef
Aquagenic palmoplantar keratoderma 5470heterozygoteCFTR-RD-causing- Undef
CFTR-RD-causing- Undef
CFTR-RD-causing- Undef
CF 5026heterozygoteCF-causing - Trans
CF 4790heterozygoteCF-causing- Undef
CF 4962heterozygoteCF-causing - Trans
Pending 1240heterozygote
Pending 4748heterozygoteCF-causing - Trans
CRS-NP 5778heterozygoteVUS3- Undef
CRS-NP 5338heterozygoteVUS3- Undef


Color code:   non disease-causing <   VUS1 <   VUS2 <   VUS3 <   VUS4 <   VUS5 <   disease-causing



            CFTR variants are clustered into five groups:
  • CF-causing: when in trans with another CF-causing mutation, will result in CF.
  • CFTR-RD causing: when in trans with a CF-causing mutation, will result in CFTR-related disorders (CFTR-RD) such as chronic pancreatitis, bronchiectasis, CRS-NP (chronic rhinosinusitis with or without nasal polyposis) or CBAVD (congenital absence of vas deferens), according to Bombieri C et al., 2011.
  • Varying clinical consequence: when in trans with another CF-causing mutation, can either result in CF or in a CFTR-RD.
  • Non disease-causing: when in trans with a CF-causing mutation, will not cause CF, nor CFTR-RD.
  • VUS (Variant of unknown clinical significance): unclassified because of insufficient data.